ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 718730 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 718730; 2) Community: the network communities that were significantly associated with the response to NSC 718730; 3) Molecule: the relationships between components within communities and NSC 718730; 4) MDR: the compounds that were significantly associated with the NSC 718730.

NSC Compound Enrichment Correlation
NSC 683326 Null 0.0295480456086945 0.48214795
NSC 700893 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) 0.0295480456086945 -0.15872734
NSC 81052 Streptonigrin analog (MeO-N3) 0.0295480456086945 0.60572127
NSC 10466 Aizen Magenta 0.0314734733353265 0.18053854
NSC 116878 Cardiac glycoside 0.0314734733353265 0.18389052
NSC 13317 Null 0.0314734733353265 0.27861605
NSC 145168 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- 0.0314734733353265 0.61675142
NSC 15812 Null 0.0314734733353265 0.33862458
NSC 219733 N,N'-Bis(9-acridinyl)-1,6-hexanediamine 0.0314734733353265 0.4293044
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0314734733353265 0.38014036
Total:126  Current:90    [First] [Prev] [Next] [Last]